CLEVELAND, Ohio, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics" or the "Company") is pleased to announce the appointment of J. David Warren, Ph.D., as Chief Executive Officer and as a director of the Company, effective October 1st, 2026.Dr. Warren brings more than two decades of experience in bioorganic chemistry, medicinal chemistry, peptide science and translational drug discovery. He is an Adjunct Associate Professor of Research in...
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four upcoming presentations, including two Late Breaking Clinical Research presentations and two oral presentations, at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2026 taking place in Phoenix, AZ from October 9 – 12, 2026.
Jena, Germany, Oct. 02, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company has been selected for a late-breaking poster session at the American Society of Nephrology’s Kidney Week 2026, taking place in Denver, Colorado, USA, October 21 - 25.
SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced that on October 1, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 128,250 shares of common stock to nine (9) new employees under the Company’s 2023 Inducement Option Plan, as amended. The Compensation Committee approved the stock options as an inducement material to such employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).
Sampo Oyj, johdon liiketoimet, 2.10.2026 klo 14.30
Sampo plc, managers’ transactions, 2 October 2026 at 2:30 pm EEST
Thunder Bay, Ontario--(Newsfile Corp. - October 2, 2026) - Vinland Lithium Inc. (TSXV: VLD) ("Vinland" or the "Company") further to its July 30, 2026, August 31, 2026, September 17, 2026, and September 25, 2026 news releases, the Company is pleased to announce that it has closed a second and final tranche of its previously announced $0.48 unit ("FT Unit") flow-through private placement financing (the "Financing") for aggregate gross proceeds of $90,800. In this second tranche close, the Company...
ROAD TOWN, British Virgin Islands, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Aura Minerals Inc. ("Aura" or the "Company") (NASDAQ: AUGO | B3: AURA33) announced today that it has signed a definitive agreement to acquire a company (“Newco”) that will hold the mining fleet, related equipment leases and dedicated workforce currently operated by a third-party contractor in three of its gold operations in Brazil — Apoena, Almas and Borborema — and to bring fleet operation and maintenance in-house (the "Insourcing"), with the transition targeted for January 2027. At MSG, the Company already operates the mine fleet directly.
MEDIOLAN, 2 października 2026 r. /PRNewswire/ – W dniach od 28 września do 2 października 2026 r. w Mediolanie we Włoszech odbywa się doroczny zjazd Europejskiego Towarzystwa Badań nad Cukrzycą (EASD). Opracowany przez Hansoh Pharma agonista receptorów glukagonopodobnego peptydu-1 i...
US$27.4 Million EXIM Financing Supports Expansion of U.S. Manufacturing Capacity for Aerospace, Defense, and Advanced Industrial Applications Highlights 6K Additive Inc. has executed a final loan agreement with the Export-Import Bank of the United States ("EXIM") for a US$27.4 million...
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Hyliion Holdings Corp. (NYSE:HYLN) securities. If you suffered a loss on your Hyliion investment and would like to explore a potential recovery under the federal securities laws, Learn about Hyliion Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Hyliion Holdings Corp. that ..